Device Trial Radar · NCT04191668
A Validation Study of the NightOwl PAT-based Home Sleep Apnea Test
Last checked: Nov 19, 2026Latest source record: Mar 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
106
Actual
Start
Dec 2, 2019
Primary completion
Feb 1, 2020
Study completion Feb 1, 2020
Sponsor
- Lead sponsor
- Ectosense NVNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 10, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the performance of a miniaturized sleep apnea test, called NightOwl. The system consists of a sensor placed on the fingertip and a cloud-based analytics software. The sensor acquires accelerometer and photoplethysmographic data. The software derives actigraphy from the former, and blood oxygen saturation and peripheral arterial tone (PAT), among other features, from the latter. In order to assess NightOwl's performance, the investigators will compare the respiratory event index (REI), defined as the number of respiratory events per hour of sleep, derived by the NightOwl system, to the apnea-hypopnea index (AHI) obtained from manual analysis of the polysomnography (PSG), which is the gold standard for sleep apnea diagnosis. The investigators will also compare the total sleep time (TST) derived by both systems. This study will be performed in a sleep lab environment.
Conditions
- Sleep Apnea
Interventions
NightOwlDevice
The NightOwl is a finger-mounted home sleep apnea testing device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pearson Correlation Between the AHITime frame: Through study completion, an average of 1 month.
- Pearson Correlation Between the TSTTime frame: Through study completion, an average of 1 month.
- The Evaluation of the Level of Agreement (Classification Accuracy) Between Patient CategorizationTime frame: Through study completion, an average of 1 month.
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Miami Lakes Laboratory
Miami Lakes, Florida
Plantation Laboratory East
Plantation, Florida
Plantation Laboratory West
Plantation, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.